Global mRNA Vaccines for Infectious Diseases Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global mRNA Vaccines for Infectious Diseases Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
mRNA Vaccines for Infectious Diseases report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global mRNA Vaccines for Infectious Diseases market is projected to reach US$ 36820 million in 2034, increasing from US$ 31050 million in 2022, with the CAGR of 2.5% during the period of 2024 to 2034. Demand from Infectious Disease and Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for mRNA Vaccines for Infectious Diseases industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, mRNA Vaccines for Infectious Diseases key companies include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. Moderna Therapeutics, CureVac, Translate Bio are top 3 players and held % share in total in 2022.
mRNA Vaccines for Infectious Diseases can be divided into Infectious Disease Vaccines and Cancer Vaccines, etc. Infectious Disease Vaccines is the mainstream product in the market, accounting for % share globally in 2022.
mRNA Vaccines for Infectious Diseases is widely used in various fields, such as Infectious Disease and Cancer, etc. Infectious Disease provides greatest supports to the mRNA Vaccines for Infectious Diseases industry development. In 2022, global % share of mRNA Vaccines for Infectious Diseases went into Infectious Disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Vaccines for Infectious Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the mRNA Vaccines for Infectious Diseases market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, mRNA Vaccines for Infectious Diseases introduction, etc. mRNA Vaccines for Infectious Diseases Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of mRNA Vaccines for Infectious Diseases market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for mRNA Vaccines for Infectious Diseases industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, mRNA Vaccines for Infectious Diseases key companies include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. Moderna Therapeutics, CureVac, Translate Bio are top 3 players and held % share in total in 2022.
mRNA Vaccines for Infectious Diseases can be divided into Infectious Disease Vaccines and Cancer Vaccines, etc. Infectious Disease Vaccines is the mainstream product in the market, accounting for % share globally in 2022.
mRNA Vaccines for Infectious Diseases is widely used in various fields, such as Infectious Disease and Cancer, etc. Infectious Disease provides greatest supports to the mRNA Vaccines for Infectious Diseases industry development. In 2022, global % share of mRNA Vaccines for Infectious Diseases went into Infectious Disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Vaccines for Infectious Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the mRNA Vaccines for Infectious Diseases market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, mRNA Vaccines for Infectious Diseases introduction, etc. mRNA Vaccines for Infectious Diseases Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of mRNA Vaccines for Infectious Diseases market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices